Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease

American Journal of Cardiology

Volumn 95, Issue 12, 2005, Pages 1456-1459

  Rana, Jamal S ^a   Mannam, Arjuna ^a   Donnell Fink, Laurel ^a   Gervino, Ernesto V ^a   Sellke, Frank W ^a   Laham, Roger J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; TREADMILL EXERCISE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, LASER; ANTICOAGULANTS; CORONARY DISEASE; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 20444442628     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.02.013     Document Type: Article

References (12)

1. M. Ruel, R.J. Laham, J.A. Parker, M.J. Post, J.A. Ware, M. Simons, F.W. Sellke Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein J Thorac Cardiovasc Surg 124 2002 28 34
2. R.J. Laham, F.W. Sellke, E.R. Edelman, J.D. Pealman, J.A. Wave, D.L. Brown, J.P. Gold, M. Simons Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery results of a phase I randomized, double-blind, placebo-controlled trial Circulation 100 1999 1865 1871
3. R.J. Laham, N.A. Chronos, M. Pike, M.E. Leimbach, J.E. Udelson, J.D. Pearlman, R.I. Pettigrew, M.J. Whitehouse, C. Yoshizawa, M. Simons Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease results of a phase I open-label dose escalation study J Am Coll Cardiol 36 2000 2132 2139
4. M. Simons, B.H. Annex, R.J. Laham, N. Kleiman, T. Henry, H. Dauerman, J.E. Udelson, E.V. Gervino, M. Pike, M.J. Whitehouse Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 double-blind, randomized, controlled clinical trial Circulation 105 2002 788 793
5. M.A. Bush, E. Samara, M.J. Whitehouse, C. Yoshizawa, D.L. Novicki, M. Pike, R.J. Laham, M. Simons, N.A. Chronos Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease J Clin Pharmacol 41 2001 378 385
6. J.E. Udelson, V. Dilsizian, R.J. Laham, N. Chronos, J. Vansant, M. Blais, J.R. Galt, M. Pike, C. Yoshizawa, M. Simons Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease Circulation 102 2000 1605 1610
7. R. Kornowski, D.S. Baim, J.W. Moses, M.K. Hong, R.J. Laham, S. Fuchs, R.C. Hendel, D. Wallace, D.J. Cohen, R.O. Bonow Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping Circulation 102 2000 1120 1125
8. R.J. Laham, M. Simons, J.D. Pearlman, K.K. Ho, D.S. Baim Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization J Am Coll Cardiol 39 2002 1 8
9. C.M. Dougherty, T. Dewhurst, W.P. Nichol, J. Spertus Comparison of three quality of life instruments in stable angina pectoris Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III J Clin Epidemiol 51 1998 569 575
10. R.J. Lederman, F.O. Mendelsohn, R.D. Anderson, J.F. Saucedo, A.N. Tenaglia, J.B. Hermiller, W.B. Hillegass, K. Rocha-Singh, T.E. Moon, M.J. Whitehouse, B.H. Annex TRAFFIC Investigators Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study) a randomised trial Lancet 359 2002 2053 2058
11. C.M. Gibson, K. Ryan, A. Sparano, J.L. Moynihan, M. Rizzo, M. Kelley, S.J. Marble, R. Laham, M. Simons, T.R. McClusky, J.T. Dodge Jr Angiographic methods to assess human coronary angiogenesis Am Heart J 137 1999 169 179
12. T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, M. Simons, D.W. Losordo, R.C. Hendel, R.O. Bonow, S.M. Eppler Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease Am Heart J 142 2001 872 880